Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cellsAsish K. Ghosh(Mayo Clinic), Neil E. Kay(Mayo Clinic)BloodMarch 31, 200910.1182/blood-2008-10-185686Cited by 140SaveCiteExport RISWatch citationsRelated PapersCombination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia|Blood|2006|293Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2–Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy|Clinical Cancer Research|2024|2Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications|British Journal of Cancer|2024|0